BJCM
CLVS

Blue Jay Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Blue Jay Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$9.28M Sell
99,101
-50,899
-34% -$3.11M 6.32% 2
2017
Q1 		$9.55M Sell
150,000
-148,982
-50% -$9.06M 4.7% 7
2016
Q4 		$13.3M Sell
298,982
-36,018
-11% -$1.27M 8.01% 1
2016
Q3 		$12.1M Buy
+335,000
New +$7.19M 6.59% 4

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Blue Jay Capital Management's CLVS Position: Q2 2017 in Review

Blue Jay Capital Management reduced its Clovis Oncology, Inc. (CLVS) stake by 34% in Q2 2017, selling an estimated $3.11M and leaving 99,101 shares worth $9.28M. The position accounts for 6.32% of the portfolio, ranked #2.

Blue Jay Capital Management first reported a position in CLVS in Q3 2016 and has held it in 4 quarters since. The position peaked at $13.3M in Q4 2016. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

  • Blue Jay Capital Management held 99,101 shares of Clovis Oncology, Inc. worth $9.28M as of Q2 2017.
  • Blue Jay Capital Management sold 50,899 Clovis Oncology, Inc. shares in Q2 2017, an estimated $3.11M.
  • Clovis Oncology, Inc. made up 6.32% of Blue Jay Capital Management's portfolio in Q2 2017, its #2 holding.
  • Blue Jay Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2016 and has held it in 4 quarters since.
  • Blue Jay Capital Management's Clovis Oncology, Inc. position peaked at $13.3M in Q4 2016.
  • 271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.